Omeros Corporation

(OMER) Trade

By |

Profile

Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.

Contact Information

Website: www.omeros.com
Main Phone: +1 206 676-5000
Address: 201 Elliott Avenue West
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98119

Issuer Information

Exchange: NSD
CEO: Gregory A. Demopulos
Employees: 173
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 19.63 $ -0.42 (-2.09%)
Last Price 19.63 Change $ -0.42 Change % -2.09 Tick N/A
Bid 19.50 Bid Size 400.00 Ask 21.30 Ask Size 100.00
Open 20.05 High 20.23 Low 19.49 Prev Close 20.05
Last Trade Volume 371,335 52 Wk Hi 25.20 52 Wk Low 8.36
Market Cap 948 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 48,292,608.00 EPS (TTM) -1.45 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 17
Number of Buys 3 12
Number of Sells 2 5
Net Activity 5000 166005
Last 10 Buys Shares
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Ray Aspiri 1,000
Peter A. Demopulos 1,000
Arnold C. Hanish 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Last 10 Sell Shares
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Marcia S. Kelbon 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Thomas J. Cable 1,000
Thomas J. Cable 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 34 34 34 34
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 26.33 26.33 26.33 26.33
Standard Deviation 7.09 7.09 7.09 7.09
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 1.5